LMAN1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.680400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.177600E-01
Normal-vs-Stage2
8.865200E-01
Normal-vs-Stage3
1.627780E-01
Normal-vs-Stage4
7.168000E-01
Stage1-vs-Stage2
9.861800E-01
Stage1-vs-Stage3
2.144400E-01
Stage1-vs-Stage4
8.091800E-01
Stage2-vs-Stage3
1.561930E-03
Stage2-vs-Stage4
7.534200E-01
Stage3-vs-Stage4
1.747570E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.685600E-01
Normal-vs-AfricanAmerican
5.717200E-01
Normal-vs-Asian
3.930400E-01
Caucasian-vs-AfricanAmerican
5.532400E-01
Caucasian-vs-Asian
1.429640E-01
AfricanAmerican-vs-Asian
7.449700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.510600E-01
Normal-vs-Female
7.655800E-01
Male-vs-Female
3.514600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.711000E-01
Normal-vs-Age(41-60Yrs)
5.221400E-01
Normal-vs-Age(61-80Yrs)
9.652800E-01
Normal-vs-Age(81-100Yrs)
8.287000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.025800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.858200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.368200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.135400E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.162240E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.133200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.004200E-01
Normal-vs-Daily Drinker
2.901400E-01
Normal-vs-Weekly Drinker
9.742000E-01
Normal-vs-Occasional Drinker
5.233600E-01
Normal-vs-Social Drinker
5.855200E-01
Non Drinker-vs-Daily Drinker
3.396400E-01
Non Drinker-vs-Weekly Drinker
3.810600E-01
Non Drinker-vs-Occasional Drinker
3.354300E-02
Non Drinker-vs-Social Drinker
8.640100E-02
Daily Drinker-vs-Weekly Drinker
1.754850E-01
Daily Drinker-vs-Occasional Drinker
1.297520E-02
Daily Drinker-vs-Social Drinker
4.437800E-02
Weekly Drinker-vs-Occasional Drinker
2.535000E-01
Weekly Drinker-vs-Social Drinker
3.193200E-01
Occasional Drinker-vs-Social Drinker
9.930600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.846600E-01
Normal-vs-Grade 2
9.911400E-01
Normal-vs-Grade 3
8.205600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.515400E-01
Grade 1-vs-Grade 3
6.164800E-01
Grade 1-vs-Grade 4
7.846600E-01
Grade 2-vs-Grade 3
2.184000E-01
Grade 2-vs-Grade 4
9.911400E-01
Grade 3-vs-Grade 4
8.205600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.355800E-01
Normal-vs-NonDiabetic
9.499600E-01
Diabetic-vs-NonDiabetic
4.412200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.324400E-01
Normal-vs-NoPancreatitis
9.395800E-01
Pancreatitis-vs-NoPancreatitis
2.204000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.052800E-01
Normal-vs-N1
8.503800E-01
N0-vs-N1
9.613600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.321000E-01
Normal-vs-TP53-NonMutant
6.945000E-01
TP53-Mutant-vs-TP53-NonMutant
4.933000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
